SBIR/STTR Research Award
Magnetic tracking for pharmacodynamic studies
Award amount
$99,915Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Quantum Magnetics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Provided by Applicant): Quantum Magnetic proposes to develop an
instrument, configured as a magnetic gradiometer, that would locate and track a
magnetic target in the human digestive tract without the use of radioactive
markers. The focus application is to track capsules that are used to study the
effects of new medication; however this method may be extended to other
applications such as the measurement of gastric motility. Once the target is
placed in the capsule, magnetized, and swallowed, its progress will be tracked
by the instrument by measuring its magnetic field. When the capsule dissolves,
the target will disintegrate, thereby losing its magnetization. The remnants of
the magnetic target may then be tracked by measuring their response to an
applied magnetic field. The magnetic tracking method will overcome many of the
disadvantages of the radioscintigraphic method and make it possible to (a) do
measurements in pregnant women and children, (b) avoid patient exposure,
however little, to radiation, (c) allow gastroenterologists to use a
significantly less expensive instrument, and (d) significantly ease target
preparation. In Phase I we will demonstrate the feasibility of the proposed
technique and specify the design of a prototype instrument to be built and
tested in Phase II.
PROPOSED COMMERCIAL APPLICATION:
The proposed research will lead to an instrument that will enable gastroenterologists
to track objects within the digestive system without using radioactive markers.
This instrument will offer significant cost savings and independence to
gastroenterologists, and will allow measurements in pregnant women and children
to study the effects of new medication. The instrument will be of interest to
gastroenterology departments and many pharmaceutical manufacturers worldwide.
Technology keywords
Not reported